Overview

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Chiglitazar, compare with Sitagliptin.
Phase:
Phase 3
Details
Lead Sponsor:
Chipscreen Biosciences, Ltd.
Treatments:
Sitagliptin Phosphate